StockData
United Health Products, Inc. logo

United Health Products, Inc. (UEEC) stock

UEECOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 0/30
$0.04−0.01 (-23.53%)

Close on Oct 19, 2026Market cap $10.25MP/E –Yield –

United Health Products r&d expenses

Research and development expenses are spending on new products and technology.

United Health Products's R&D Expenses for the twelve months ending Sep 30, 2026 was $48.06K, down 86.0% year over year. For fiscal 2025 it was $269.87K, down 24.2% from the year before. The highest annual figure on record is $666.39K in fiscal 2019.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$269.87K-24.2%
FY2024Dec 31, 2024$355.94K-40.6%
FY2023Dec 31, 2023$598.81K-4.1%
FY2022Dec 31, 2022$624.56K+163.0%
FY2021Dec 31, 2021$237.46K-3.2%
FY2020Dec 31, 2020$245.22K-63.2%
FY2019Dec 31, 2019$666.39K+766.0%
FY2018Dec 31, 2018$76.95K+286.0%
FY2017Dec 31, 2017$19.94K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.68K-92.6%
Q2 FY2026Jun 30, 2026$3.85K-95.2%
Q1 FY2026Mar 31, 2026$12.56K-89.2%
Q4 FY2025Dec 31, 2025$28.96K-73.4%
Q3 FY2025Sep 30, 2025$36.20K-45.1%
Q2 FY2025Jun 30, 2025$80.98K+23.2%
Q1 FY2025Mar 31, 2025$116.25K+0.6%
Q4 FY2024Dec 31, 2024$108.78K-29.0%
Q3 FY2024Sep 30, 2024$65.89K-45.9%
Q2 FY2024Jun 30, 2024$65.72K-37.5%
Q1 FY2024Mar 31, 2024$115.55K-47.2%
Q4 FY2023Dec 31, 2023$153.26K-26.9%
Q3 FY2023Sep 30, 2023$121.76K-43.4%
Q2 FY2023Jun 30, 2023$105.11K-28.8%
Q1 FY2023Mar 31, 2023$218.68K+317.7%
Q4 FY2022Dec 31, 2022$209.62K+131.3%
Q3 FY2022Sep 30, 2022$214.98K+988.1%
Q2 FY2022Jun 30, 2022$147.61K+114.3%
Q1 FY2022Mar 31, 2022$52.36K-10.0%
Q4 FY2021Dec 31, 2021$90.64K-41.3%
Q3 FY2021Sep 30, 2021$19.76K-67.1%
Q2 FY2021Jun 30, 2021$68.88K+264.7%
Q1 FY2021Mar 31, 2021$58.18K+393.6%
Q4 FY2020Dec 31, 2020$154.50K-43.6%
Q3 FY2020Sep 30, 2020$60.04K-60.0%
Q2 FY2020Jun 30, 2020$18.89K-91.2%
Q1 FY2020Mar 31, 2020$11.79K-57.0%
Q4 FY2019Dec 31, 2019$274.13K–
Q3 FY2019Sep 30, 2019$149.99K–
Q2 FY2019Jun 30, 2019$214.86K–
Q1 FY2019Mar 31, 2019$27.41K–

More United Health Products figures

See a number that looks wrong?